Alyeska Investment Group
ORKA

Alyeska Investment Group’s Oruka Therapeutics ORKA Stock Holding History

Alyeska Investment Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.07M Buy
184,863
+84,863
+85% +$2.95M 0.03% 414
2025
Q4 		$3.03M Buy
+100,000
New +$2.79M 0.01% 495

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Alyeska Investment Group's ORKA Position: Q1 2026 in Review

Alyeska Investment Group increased its Oruka Therapeutics (ORKA) stake by 85% in Q1 2026, buying an estimated $2.95M and bringing the position to 184,863 shares worth $9.07M. The position accounts for 0.03% of the portfolio, ranked #414.

Alyeska Investment Group first reported a position in ORKA in Q4 2025 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Alyeska Investment Group held 184,863 shares of Oruka Therapeutics worth $9.07M as of Q1 2026.
  • Alyeska Investment Group bought 84,863 Oruka Therapeutics shares in Q1 2026, an estimated $2.95M.
  • Oruka Therapeutics made up 0.03% of Alyeska Investment Group's portfolio in Q1 2026, its #414 holding.
  • Alyeska Investment Group first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.